Skip to content

Prevalence of asymptomatic deep vein thrombosis in admitted COVID-19 patients

Prevalence of asymptomatic deep vein thrombosis in admitted COVID-19 patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON25962
Enrollment
100
Registered
2020-04-30
Start date
2020-04-19
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID and DVT

Interventions

None

Sponsors

UMCG
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Age (= 18 years) - Proven (PCR) or suspected (based on clinical signs and imaging) COVID-19 infection - Certified sonographer present

Exclusion criteria

Exclusion criteria: - Clinical suspicion of DVT - No informed consent obtained - Absence of COVID infection

Design outcomes

Primary

MeasureTime frame
Prevalence of VTE

Secondary

MeasureTime frame
Patient- and treatment characteristics associated with increased DVT risk

Contacts

Public ContactHilde Kooistra

UMCG

h.a.m.kooistra@umcg.nl+31621258853

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)